Homebiotech

biotech

biotech

Vedana Therapeutics launches to develop migraine therapies

Jim Cornall - June 25, 2026

biotech

Memento Medicines launches with $93m to develop antibody therapy for retinal diseases

Jim Cornall - June 25, 2026

biotech

Meteor Biotech joins brain organoids consortium

Jim Cornall - June 25, 2026

biotech

Can food influence gene activity?

Jim Cornall - June 24, 2026

biotech

New molecular degraders offer hope in aggressive breast cancer fight

Jim Cornall - July 23, 2025

biotech

Cells repair toxic DNA damage linked to cancer and premature ageing

Jim Cornall - July 23, 2025

biotech

Elix provides AI drug discovery platform to Eisai

Jim Cornall - July 23, 2025

biotech

Johnson & Johnson receives Priority Review for high-risk non-muscle invasive bladder cancer treatment

Jim Cornall - July 22, 2025

biotech

Bakar Labs to build new R&D facility for biotechs

Jim Cornall - July 22, 2025

biotech

Sanofi to acquire vaccine biotech Vicebio for $1.6bn

Jim Cornall - July 22, 2025

biotech

Elix and LINC combine on new drug discovery platform

Jim Cornall - July 21, 2025

biotech

FDA grants orphan drug designation to gene therapy for ALS

Jim Cornall - July 21, 2025

1...727374...85 Page 73 of 85

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Vedana Therapeutics launches to develop migraine therapies

Jim Cornall - June 25, 2026 0

Vedana Therapeutics, a biotechnology company developing next-generation therapies for migraine prevention, has emerged from stealth with $46m in Series A financing. The financing was co-led...

Memento Medicines launches with $93m to develop antibody therapy for retinal diseases

biotech Jim Cornall - June 25, 2026 0

Meteor Biotech joins brain organoids consortium

biotech Jim Cornall - June 25, 2026 0

Can food influence gene activity?

biotech Jim Cornall - June 24, 2026 0

Lab-engineered proteins: a promising treatment for liver disease

biotech Jim Cornall - June 24, 2026 0